Peripheral Neuropathy Trial, Recruiting (NCT04278118)

Peripheral Neuropathy Trial, Recruiting NCT04278118 Sponsor: Emory University Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04278118 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a non-cancerous brain or nerve tumor (such as a meningioma, pituitary adenoma, or schwannoma) confirmed by a biopsy or medical imaging scan — certain higher-grade meningiomas (WHO grade 2–3) are also included
Your doctors have recommended that you receive a type of radiation therapy called proton or photon fractionated radiation treatment
You are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

You are pregnant, or if you are a woman who could become pregnant and you are unwilling or unable to use effective birth control during the study (confirm with trial site)
You are a woman who could become pregnant and you are unable to take a pregnancy test before starting treatment (confirm with trial site)
You have previously had radiation therapy to an area of the body that overlaps with the area that would need to be treated in this trial
You are unable to have an MRI scan (for example, due to having certain metal implants or severe claustrophobia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04278118

Sponsor: Emory University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

More information: https://clinicaltrials.gov/study/NCT04278118

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a non-cancerous brain or nerve tumor (such as a meningioma, pituitary adenoma, or schwannoma) confirmed by a biopsy or medical imaging scan — certain higher-grade meningiomas (WHO grade 2–3) are also included
Your doctors have recommended that you receive a type of radiation therapy called proton or photon fractionated radiation treatment
You are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

You are pregnant, or if you are a woman who could become pregnant and you are unwilling or unable to use effective birth control during the study (confirm with trial site)
You are a woman who could become pregnant and you are unable to take a pregnancy test before starting treatment (confirm with trial site)
You have previously had radiation therapy to an area of the body that overlaps with the area that would need to be treated in this trial
You are unable to have an MRI scan (for example, due to having certain metal implants or severe claustrophobia)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

18 February 2020

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

local tumor control; Incidence of adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov